Cargando…
Myasthenic crisis in COVID-19
• Myasthenic crises is a potentially severe complication of COVID-19. • Hydroxychloroquine can aggravate myasthenia crises. • IVIg is a potential treatment for both Myasthenic crises and COVID-19. • IVIg treatment may cause thrombosis in susceptible patients.
Autores principales: | Delly, Fadi, Syed, Maryam J., Lisak, Robert P., Zutshi, Deepti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200364/ https://www.ncbi.nlm.nih.gov/pubmed/32413767 http://dx.doi.org/10.1016/j.jns.2020.116888 |
Ejemplares similares
-
Reply from the authors: Myasthenic crises in COVID-19
por: Syed, Maryam J., et al.
Publicado: (2020) -
Myasthenic crisis due to anxiety and insomnia during COVID -19 pandemic
por: Kalita, Jayantee, et al.
Publicado: (2020) -
Takotsubo Cardiomyopathy associated with myasthenic crisis: An Illustrative Case
por: Biswas, Sutapa, et al.
Publicado: (2020) -
An atypical Takotsubo cardiomyopathy in a typical myasthenic crisis
por: Antenucci, Pietro, et al.
Publicado: (2023) -
Pembrolizumab-Induced Myasthenic Crisis with HyperCKemia in a Patient with Thymoma
por: Shin, Ji Hye, et al.
Publicado: (2020)